No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Biocon Announces Positive Ph 3 Results for Biosimilar Ustekinumab
On 7 March 2025, Biocon Biologics announced the results of a Phase 3 study comparing Yesintek™ (biosimilar ustekinumab) with J&J/Janssen’s Stelara® in adults with moderate to severe chronic…